Cargando…

Retinoic acid-producing DCs and gut-tropic FOXP3(+) regulatory T cells in the induction of oral tolerance

The systemic unresponsiveness of the immune system to orally administered antigens is known as oral tolerance. Recent findings describe a new step for the induction of oral tolerance, consisting in the homing of FOXP3(+) regulatory T cells to the small bowel and the local acquisition of full immunos...

Descripción completa

Detalles Bibliográficos
Autor principal:	Villablanca, Eduardo J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601169/ https://www.ncbi.nlm.nih.gov/pubmed/23526672 http://dx.doi.org/10.4161/onci.22987

Ejemplares similares

Retinoic acid on stage in antitumor immunity
por: Guo, Yanxia, et al.
Publicado: (2013)

slanDCs in carcinoma-draining lymph nodes
por: Vermi, William, et al.
Publicado: (2014)

FOXP3-specific immunity
por: Andersen, Mads Hald
Publicado: (2013)

Drag cells in immunity: Plasmacytoid DCs dress up as cancer cells
por: Bonaccorsi, Irene, et al.
Publicado: (2014)

Plasmacytoid dendritic cells deficient in IFNα production promote the amplification of FOXP3(+) regulatory T cells and are associated with poor prognosis in breast cancer patients
por: Sisirak, Vanja, et al.
Publicado: (2013)

Neuropilin 1 guides regulatory T cells into VEGF-producing melanoma
por: Hansen, Wiebke
Publicado: (2013)

The role of FOXP3 in disease progression in colorectal cancer patients
por: Grimmig, Tanja, et al.
Publicado: (2013)

Modulating gut immunity and neoplasia with oral cytokine adjuvants
por: Ozbilge, Hatice, et al.
Publicado: (2015)

New role for antigen-presenting activated pDCs in promoting Th17 cells and impacting antitumor immunity
por: Guéry, Leslie, et al.
Publicado: (2015)

Activation of antigen-exposed iMC-DCs at the “right place” and “right time” promotes potent anti-tumor immunity
por: Spencer, David M.
Publicado: (2012)

Antibody-based depletion of Foxp3+ T cells potentiates antitumor immune memory stimulated by mTOR inhibition
por: Kim, Hyung L
Publicado: (2014)

Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment
por: Jinushi, Masahisa
Publicado: (2012)

Interferon α interferes with immunological tolerance
por: Becker, Christian, et al.
Publicado: (2013)

How to outsmart NK cell tolerance
por: Terszowski, Grzegorz, et al.
Publicado: (2015)

The two faces of regulatory T cells in cancer
por: Blatner, Nichole R, et al.
Publicado: (2013)

Induction of pyroptosis in colon cancer cells by LXRβ
por: Rébé, Cédric, et al.
Publicado: (2015)

Hunting for clues: Regulatory T cells and colorectal cancer
por: Gallimore, Awen, et al.
Publicado: (2012)

Synchronous apoptosis in established tumors leads to the induction of adaptive immunity
por: Honeychurch, Jamie, et al.
Publicado: (2013)

Colon cancer cells produce immunoregulatory glucocorticoids
por: Sidler, Daniel, et al.
Publicado: (2012)

Peripheral T-cell tolerance in hosts with acute myeloid leukemia
por: Chen, Xiufen, et al.
Publicado: (2013)

Toward understanding the genetics of regulatory T cells in ovarian cancer
por: DeRycke, Melissa S, et al.
Publicado: (2013)

Targeting the right regulatory T-cell population for tumor immunotherapy
por: Weiss, Vivian L., et al.
Publicado: (2012)

Gut microbiota and colon cancer: the carbohydrate link
por: Belcheva, Antoaneta, et al.
Publicado: (2014)

A novel facet of tumor suppression by p53: Induction of tumor immunogenicity
por: Li, Hai, et al.
Publicado: (2012)

A new strategy to target regulatory T cells in solid tumors
por: Thomas-Schoemann, Audrey, et al.
Publicado: (2013)

DNA damage tolerance branches out toward sister chromatid cohesion
por: Branzei, Dana
Publicado: (2015)

‘Hardcore’ OX40(+) immunosuppressive regulatory T cells in hepatic cirrhosis and cancer
por: Piconese, Silvia, et al.
Publicado: (2014)

Contribution of regulatory T cells to immunosuppression and disease progression in multiple myeloma patients
por: Raja, Karthick Raja Muthu, et al.
Publicado: (2013)

Interleukin-2 treatment of tumor patients can expand regulatory T cells
por: Beyer, Marc
Publicado: (2012)

Activin A backs-up TGF-ß to promote regulatory T cells
por: De Martino, Mara, et al.
Publicado: (2021)

Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia
por: Williams, Mark S., et al.
Publicado: (2020)

FOXO3: A master switch for regulating tolerance and immunity in dendritic cells
por: Watkins, Stephanie K., et al.
Publicado: (2012)

Split T-cell tolerance as a guide for the development of tumor antigen-specific immunotherapy
por: Tsuji, Takemasa, et al.
Publicado: (2012)

Know thy enemy: Why are tumor-infiltrating regulatory T cells so deleterious?
por: Facciabene, Andrea, et al.
Publicado: (2012)

Plasmacytoid dendritic cells and regulatory T cells in the tumor microenvironment: A dangerous liaison
por: Conrad, Curdin, et al.
Publicado: (2013)

Organ-specific regulatory T cells of thymic origin are expanded in murine prostate tumors
por: Malchow, Sven, et al.
Publicado: (2013)

Regulatory T cells are redirected to kill glioblastoma by an EGFRvIII-targeted bispecific antibody
por: Choi, Bryan D, et al.
Publicado: (2013)

IP-10/CXCL10 attracts regulatory T cells: Implication for pancreatic cancer
por: Lunardi, Serena, et al.
Publicado: (2015)

C3G self-regulatory mechanism revealed: implications for hematopoietic malignancies
por: Carabias, Arturo, et al.
Publicado: (2020)

Why should we need the gut microbiota to respond to cancer therapies?
por: Viaud, Sophie, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_h9n3un9808ao4ogfh7vhgoposa